RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2020-12-09

Reporting Person: TETRAULT LYNN A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-09	Stock Option (Right to Buy)	$28.27	A	37000	Acquired	2030-12-08	Common Stock (37000)	Direct

Footnotes

F1: One-third of the options will vest on each one-year anniversary of the grant date, with the first one-third vesting on December 9, 2021.